Dallah Healthcare Co (SAU:4004) Other Financing: ﷼-862 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4004 Dallah Healthcare Co SAU:4004
92 GF Score
Price ﷼84.05
GF Value ﷼164.41
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Dallah Healthcare Co Other Financing?

Dallah Healthcare Co SAU:4004 -1.58% 92 Other Financing is ﷼-862 Mil as of Jun. 2026. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼164.41 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Dallah Healthcare Co's Other Financing for the three months ended in Jun. 2026 was ﷼-163 Mil.

Dallah Healthcare Co's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼-862 Mil.

Dallah Healthcare Co Other Financing Historical Data

* Premium members only.

The historical data trend for Dallah Healthcare Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dallah Healthcare Co Other Financing Chart

Dallah Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.25 -101.89 -117.46 -96.20 -609.37

Dallah Healthcare Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -143.72 -95.03 -564.89 -39.92 -162.61
SAU:4004
92GF Score
Dallah Healthcare Co SAU:4004
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dallah Healthcare Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼-862 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ﷼-862 Mil mean?
Dallah Healthcare Co (SAU:4004) has a Other Financing of ﷼-862 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Dallah Healthcare Co and its competitors.
Is Dallah Healthcare Co's Other Financing too high?
Dallah Healthcare Co's current Other Financing is ﷼-862 Mil. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Other Financing compare to HCA and THC?
Dallah Healthcare Co's Other Financing of ﷼-862 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Dallah Healthcare Co and its competitors. Dallah Healthcare Co's current Other Financing is ﷼-862 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼164.41, compared to a current price of ﷼84.05 — trading 48.9% below its estimated fair value. The current Other Financing is ﷼-862 Mil. Dallah Healthcare Co's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Other Financing is ﷼-862 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?

Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued. The current stock price of ﷼84.05 is trading 48.9% below its estimated GF Value™ of ﷼164.41. GuruFocus considers Dallah Healthcare Co to be Significantly Undervalued.

Key valuation signals for SAU:4004:

  • Other Financing: ﷼-862 Mil
  • GF Value™: ﷼164.41 vs. price of ﷼84.05 (48.9% below fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dallah Healthcare Co Business Description

Address 1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score

Get the complete analysis for SAU:4004

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼84.05
Price
﷼164.41
GF Value